UCB SA (UCB)
Euronext
Real-time Data
07:00 AM
Day's Range
199.8552 wk Range
198.75Overview - UCB - UCB SA
Key Statistics
Valuation
Enterprise Value
43.70B
P/E (Trailing)
‪18.93‬
P/E (Forward)
‪15.55‬
PEG Ratio
‪15.55‬
Price / Sales (TTM)
‪4.79‬
Price / Book
‪3.50‬
EV / EBITDA
‪13.07‬
Profitability
Profit Margin
‪25.73%‬
Operating Margin
‪33.32%‬
Return on Assets
‪8.97%‬
Return on Equity
‪20.56%‬
Ownership
Shares Outstanding
190.36M
Float
120.15M
Held by Insiders
‪36.27%‬
Held by Institutions
‪39.25%‬
Price stats
Beta
‪0.17‬
50-Day Avg
‪221.35‬
200-Day Avg
‪245.09‬
Dividends
Payout Ratio
‪12.81%‬
Frequency
Annual
Analyst Consensus
20 analysts
Average price target
‪€ 285.26‬Market Cap - UCB - UCB SA
Peers - UCB - UCB SA
Peer Comparison
Compared with companies in Biotechnology listed on Euronext.
- UCBEuronextUCB SA40.87BMarket Cap-6.16%52-week change18.94P/E (Trailing)‪25.73%‬Profit Margin
- ARGXEuronextargenx SE52.87BMarket Cap+27.69%52-week change36.64P/E (Trailing)‪32.26%‬Profit Margin
- AGNEuronextAegon Ltd.11.21BMarket Cap+10.13%52-week change11.66P/E (Trailing)‪8.62%‬Profit Margin
- ABVXEuronextAbivax SA7.14BMarket Cap+13.43%52-week change-16.96P/E (Trailing)‪0.00%‬Profit Margin
- ALVIOEuronextValerio Tx Corp.279.69MMarket Cap+89.64%52-week change—P/E (Trailing)‪-190.36%‬Profit Margin
- AVTXEuronextAvantium N.V.126.03MMarket Cap-46.80%52-week change-2.94P/E (Trailing)‪-154.30%‬Profit Margin
- ALCLSEuronextCellectis S.A.125.69MMarket Cap-81.49%52-week change-1.86P/E (Trailing)‪-102.33%‬Profit Margin
Profile Summary - UCB - UCB SA
About
UCB SA is a multinational biopharmaceutical company headquartered in Brussels, Belgium, founded in 1928 by Emmanuel Janssen. It specializes in developing innovative medicines for severe neurological and immunological diseases, including epilepsy, Parkinson's disease, Crohn's disease, psoriasis, and autoimmune…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
